(Circulation. 2008;118:e689.)
© 2008 American Heart Association, Inc.
Correspondence |
National Heart, Lung, and Blood Institutes Framingham Heart Study, Framingham, Mass
Department of Biostatistics, Boston University School of Public Health, Boston, Mass
Center of Human Development and Aging, University of Medicine and Dentistry of New Jersey, Newark, NJ
Center for Cardiovascular Disease Prevention, Brigham and Womens Hospital, Harvard Medical School, Boston, Mass
Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass
National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md
We would like to thank Dr Huzen and colleagues for their suggestion. Indeed, we are conducting several additional analyses relating telomere length to other markers of the renin-angiotensin-aldosterone system and related pathways, including relating telomere length to measures of left ventricular hypertrophy. We deemed it beyond the scope of the original article1 to present a comprehensive analysis of multiple phenotypes and chose to focus on direct markers of the renin-angiotensin-aldosterone system as reflected by circulating biomarkers.
| Acknowledgments |
|---|
None.
| Reference |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |